How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read More
1 Cloud SaaS Healthcare Stock to Buy on the Dip?
It might surprise many that Veeva Systems Inc. (NYSE:VEEV), best known for its cloud-based software solutions tailored to the life sciences industry, has maintained a core principle of putting customer success and product excellence ahead of short-term gains.
In a market crowded with SaaS companies seeking to serve a wide variety of enterprises,
» Read more about: 1 Cloud SaaS Healthcare Stock to Buy on the Dip? »
Read More
NVIDIA Investing In Tiny Robotics Firm, Should You Follow?
NVIDIA gets a lot of attention for designing some of the world’s most powerful GPUs. It’s difficult to imagine that the recent advancements in artificial intelligence would have happened without NVIDIA. After all, OpenAI trained ChatGPT with 10,000 NVIDIA GPUs connected to a Microsoft supercomputer.
But NVIDIA actually does much more than build efficient processing units.
» Read more about: NVIDIA Investing In Tiny Robotics Firm, Should You Follow? »
Read More
Is Michael Saylor’s Bet Crazy: Bull vs Bear
Microstrategy (NASDAQ:MSTR) and its CEO Michael Saylor are in large part confounding valuation experts worldwide.
The traditional method of valuing a company goes something like this. Analyze the cash flows a company will produce over its lifetime, discount them back to present day, sum them up and arrive at a fair market valuation for the company.
» Read more about: Is Michael Saylor’s Bet Crazy: Bull vs Bear »
Read More
I Finally Found an 8% Yielder
Real estate, REITs, dividend stocks, you name it. I’m always looking for new ways to make my money work while I sleep. And one stock I found that’s super interesting for passive income is Main Street Capital (NASDAQ: MAIN).
It has the hallmarks of being one of the best passive income machines I’ve seen,
» Read more about: I Finally Found an 8% Yielder »
Read MoreThe Ivy
Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift
Cava Group has done what its customers do best: dip. After hitting an all-time high near $172 last November, the shares have slid to the high-$60s, roughly a 60% slide from the peak, even though the business keeps putting up solid numbers.
That kind of disconnect tends to create opportunity for patient investors who care more about unit economics than headlines.
» Read more about: Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift »
Read MoreThe Spotlight
Can Ray Dalio’s All-Weather Blueprint Shield Your Portfolio?
When storms hit the financial markets, most investors scramble for cover. But what if you could build a portfolio designed to weather any storm, one that doesn’t flinch when stocks sink, inflation spikes, or economic growth stalls?
That was the question billionaire Ray Dalio sought to answer when he created his now-famous All Weather portfolio,
» Read more about: Can Ray Dalio’s All-Weather Blueprint Shield Your Portfolio? »
Read MoreThe Daily
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Moves Higher As Amazon Gains 4.7%
Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties,